Feasibility study of two schedules of sunitinib in combination with pemetrexed in patients with advanced solid tumors

By Okamoto Isamu  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 639-646

Springer Publishing Company

Access to resources Recommend Favorite

A phase I Study with oral SU5416 in patients with advanced solid tumors: A drug inducing its clearance

By Salzberg Marc   Pless Miklos   Rochlitz Christoph   Ambrus Klara   Scigalla Paul   Herrmann Richard  

Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. : 299-304

Springer Publishing Company

Access to resources Recommend Favorite

Sunitinib combined with pemetrexed and carboplatin in patients with advanced solid malignancies—results of a phase I dose-escalation study

By Blais Normand   Camidge D.   Jonker Derek   Soulières Denis   Laurie Scott   Diab Sami   Ruiz-Garcia Ana   Thall Aron   Zhang Ke   Chao Richard   Chow Laura  

Investigational New Drugs, Vol. 31, Iss. 6, 2013-12 ,pp. : 1487-1498

Springer Publishing Company

Access to resources Recommend Favorite

A prospective multicenter phase II study of sunitinib in patients with advanced aggressive fibromatosis

By Jo Jae-Cheol   Hong Yong   Kim Kyu-Pyo   Lee Jae-Lyun   Lee Jeeyun   Park Young   Kim Sun   Ryu Jin-Sook   Lee Jong-Seok   Kim Tae  

Investigational New Drugs, Vol. 32, Iss. 2, 2014-04 ,pp. : 369-376

Springer Publishing Company

Access to resources Recommend Favorite

Phase I clinical and pharmacokinetic study of trabectedin and carboplatin in patients with advanced solid tumors

By Vidal Laura  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 616-628

Springer Publishing Company

Access to resources Recommend Favorite